• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Status epilepticus: Refractory and super-refractory
Deepanshu Dubey, Jayantee Kalita, Usha K MisraNeurology India 2017 65(7):12-17Status epilepticus (SE) is an important neurological emergency. It is defined as seizures lasting for 5 minutes or more or recurrent seizures without recovery of consciousness to baseline between the attacks. Refractory SE (RSE) is defined as SE persisting despite sufficient dose of benzodiazepines and at least one antiepileptic drug (AED), irrespective of time. Super refractory SE (SRSE) is defined as SE that continues for 24 hours or more after the use of anesthetic therapy, including cases that recur on weaning of the anesthestic agent. RSE oc...
Source: Neurology India - March 7, 2017 Category: Neurology Authors: Deepanshu Dubey Jayantee Kalita Usha K Misra Source Type: research

Antiepileptic Drug Prescribing for OEF/OIFVeterans with New-Onset Epilepsy: 2008-2010 (S59.004)
CONCLUSIONS: Our examination of prescribing patterns found that slightly over half of individuals with new epilepsy were treated using newer AEDs and 94% received monotherapy. Despite lack of FDA approval or recommendation by the AES, AAN or the ILAE for the use of levetiracetam monotherapy in the treatment of new onset epilepsy, levetiracetam monotherapy was the most common single medication prescribed. Moreover, nearly 40% of women in childbearing age received valproate or topiramate, which have been identified as teratogenic. Further research is needed to evaluate the quality of prescribing for women.Study Supported by:...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Pugh, M. J., Van Cott, A., Baca, C., Amuan, M. Tags: Epilepsy and Clinical Neurophysiology (EEG): Reproduction, Health Care Delivery, and Co-morbidities Source Type: research

Antiepileptic Drug Prescribing for OEF/OIFVeterans with New-Onset Epilepsy: 2008-2010 (I8-1.009)
CONCLUSIONS: Our examination of prescribing patterns found that slightly over half of individuals with new epilepsy were treated using newer AEDs and 94% received monotherapy. Despite lack of FDA approval or recommendation by the AES, AAN or the ILAE for the use of levetiracetam monotherapy in the treatment of new onset epilepsy, levetiracetam monotherapy was the most common single medication prescribed. Moreover, nearly 40% of women in childbearing age received valproate or topiramate, which have been identified as teratogenic. Further research is needed to evaluate the quality of prescribing for women.Study Supported by:...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Pugh, M. J., Van Cott, A., Baca, C., Amuan, M. Tags: Clinical Decision Making After the Dust Settles on Clinical Trials Poster Presentations Source Type: research